(firstQuint)S-1 and Radiotherapy for Elderly Esophageal Cancer Patients.

 Older patients with esophageal cancer have been correlated with poor prognosis because of having little chance to receive aggressive local therapy, including concurrent chemoradiotherapy.

 In this phase II trial, the efficacy and toxicity of S-1 with concurrent radiotherapy will be investigated in this setting.

.

 S-1 and Radiotherapy for Elderly Esophageal Cancer Patients@highlight

To investigate the efficacy and toxicity of S-1 with concurrent radiotherapy in older patients with esophageal cancer.

